Log in to save to my catalogue

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8604724

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

About this item

Full title

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2021-11, Vol.27 (11), p.2032-2040

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

The global supply of COVID-19 vaccines remains limited. An understanding of the immune response that is predictive of protection could facilitate rapid licensure of new vaccines. Data from a randomized efficacy trial of the ChAdOx1 nCoV-19 (AZD1222) vaccine in the United Kingdom was analyzed to determine the antibody levels associated with protecti...

Alternative Titles

Full title

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8604724

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8604724

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/s41591-021-01540-1

How to access this item